Human immunogenic T cell epitopes in nucleoprotein of human influenza A (H5N1) virus

Hong Kong Medical Journal

Volumn 18, Issue SUPP2, 2012, Pages 17-21

  Cheung, Y K ^a   Cheng, S C S ^a   Ke, Y ^a   Xie, Yong ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLMETHIONYLASPARTYLSERYLASPARGYLTHREONYLLEUCYLGLUTAMYLLEUCINE; DNA VACCINE; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHENYLALANYLGLUTAMYLGLYCYLARGINYLGLYCYLVALYLPHENYLALANYLGLUTAMYLLEUCINE; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; INFLUENZA VACCINE; NUCLEOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H5N1; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL CULTURE; IMMUNOLOGY; INFLUENZA; METABOLISM; MOUSE; ORTHOMYXOVIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; MICE; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84861569921     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004;430:209-13.
2. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79.
3. Cheung YK, Cheng SC, Sin FW, Chan KT, Xie Y. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope. Vaccine 2007;25:6070-7.
4. Dutoit V, Taub RN, Papadopoulos KP, et al. Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting. J Clin Invest 2002;110:1813-22.
5. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and crosspresentation. Immunol Rev 2005;207:145-57.